Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03663166
Title Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

lung non-small cell carcinoma

Therapies

Cisplatin + Ipilimumab + Pemetrexed Disodium

Nivolumab

Carboplatin + Ipilimumab + Paclitaxel

Cisplatin + Etoposide + Ipilimumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
UNC Limeberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Duke University Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field